+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Home Healthcare Market Size, Share & Trends Analysis Report by Equipment (Therapeutic, Diagnostic), by Services (Skilled Home Healthcare Services, Unskilled Home Healthcare Services), by Region, and Segment Forecasts, 2022-2030

  • PDF Icon

    Report

  • 252 Pages
  • April 2022
  • Region: Global
  • Grand View Research
  • ID: 5450245
Description Jump to:
The global home healthcare market size is expected to reach USD 634.9 billion by 2030. The market is expected to expand at a CAGR of 7.9% from 2022 to 2030. This growth can be attributed to cost-efficiency, improved patient outcomes, and convenience offered by home healthcare agencies. In addition, the rising geriatric population and the growing prevalence of chronic diseases such as Alzheimer’s, dementia, and orthopedic conditions, are expected to drive market growth. As per the Population Reference Bureau data updated in June 2019, the number of people aged 65 years and above was 52 million in 2018 and is projected to double by 2060 to reach 95 million.



The World Health Organization (WHO) statistics state that there are around 50 million dementia patients in the world with 10 million new cases getting added every year. This number is expected to reach 82 million by 2030. The elderly population is expected to outnumber the children population in the span, which is a demographic shift and poses to be a public health challenge. Besides, the maintenance and establishment of hospitals and other healthcare settings need high capital investment. Some of the healthcare solutions providers are following merger and acquisition strategy to enter the market, in order to provide cost-effective service and leverage the expertise of the merged or acquired firm. Also, shifting trends toward in-home healthcare services for patients to avoid hospital stays is another key factor driving the market growth.

During the COVID-19 pandemic, the majority of the nursing facilities were significantly impacted, while the in-home services aided the majority of healthcare providers to offer their services in a safe environment. The demand for home care services is expected to increase in the immediate future, owing to the ongoing COVID-19 pandemic. These services are safer and cost-effective alternatives to hospital services. External substitutes, including hospitals, informal care, and other healthcare establishments, pose a limited threat, mostly due to their high costs. Thus, the threat of substitutes in the market is expected to be moderate during the forecast period.

Home Healthcare Market Report Highlights

  • The services segment dominated the market in 2021 attributed to the growing demand for skilled nurse in-home care for services like physical and occupational therapy.
  • Growing demand for skilled nurses for rehabilitation services, wound dressings, tube feedings, and maintaining stable patient health is driving the growth of the segment. Mainly, patients suffering major trauma due to accidents or those suffering from strokes opt for rehabilitation services for improving their way of talking, walking, and feeding themselves all over again.
  • The demand for home therapeutic equipment is increasing due to the rising prevalence of chronic conditions such as respiratory diseases, kidney disorders, and diabetes. The segment is expected to witness the highest CAGR during the forecast period.
  • Advancement in technology is likely to favor the growth of the market. For instance, active home telemonitoring devices can help in capturing vital signs and symptoms which helps the home health agency.
  • North America is the most mature region of the market. The presence of a large geriatric population in this region coupled with sophisticated healthcare infrastructure and relatively higher patient disposable income levels are some of the key factors.
  • Europe held a significant share of the market in 2021. With the ongoing COVID-19 pandemic, the demand for nurses, attendants, physicians, physiotherapists, and caregivers is expected to rise, with home care services being considered a safer alternative to hospital services.

Table of Contents

Chapter 1 Report Scope
1.1 Market Segmentation
1.2 Regional Scope
Chapter 2 Market Definition
2.1 Equipment
2.1.1 Therapeutic
2.1.1.1 Home respiratory therapy
2.1.1.2 Insulin delivery
2.1.1.3 Home IV (intravenous) pumps
2.1.1.4 Home dialysis equipment
2.1.2 Diagnostics
2.1.2.1 Diabetic care unit
2.1.2.2 Blood pressure monitors
2.1.2.3 Multi parameter diagnostic monitors
2.1.2.4 Home pregnancy and fertility kits
2.1.2.5 Apnea and sleep monitors
2.1.2.6 Holter monitors
2.1.2.7 Heart rate meters
2.1.3 Mobility Assist Equipment
2.1.3.1 Wheelchair
2.1.3.2 Home medical furniture
2.1.3.3 Walking assist devices
2.2 Service
2.2.1 Skilled home healthcare
2.2.2 Unskilled home healthcare
2.3 Estimates and Forecast Timeline
Chapter 3 Methodology
3.1 Research Methodology
3.1.1 Information procurement
3.1.2 Purchased Database
3.1.3 Internal Database
3.1.4 Secondary Sources
3.1.5 Primary Research
3.2 Information or Data Analysis
3.2.1 Data Analysis Models
3.3 Market Formulation & Validation
3.4 Region Wise Market Calculation
3.4.1 Region Wise Market: Base Estimates
3.4.2 Global Market: CAGR Calculation
3.5 Region Based Segment Share Calculation
3.6 Model Details
3.6.1 Commodity flow analysis
3.6.2 Volume price analysis
3.7 List of Secondary Sources
3.8 List of Abbreviations
Chapter 4 Objectives
4.1 Objective-1
4.2 Objective-2
4.3 Objective-3
Chapter 5 Executive Summary
Chapter 6 Industry Outlook
6.1 Market Lineage outlook
6.1.1 Parent market outlook
6.1.2 Related/ancillary market outlook
6.2 User Perspective Analysis
6.2.1 Consumer Behavior Analysis
6.3 Business Segment Trends
6.3.1 Product business analysis
6.3.2 regional business analysis
6.4 Market Dynamics
6.4.1 Market driver analysis
6.4.1.1 Home healthcare as a cost-effective alternative
6.4.1.2 Growing geriatric population
6.4.1.3 Hospital solution providers penetrating the home healthcare market
6.4.1.4 Growing prevalence of target diseases, especially Alzheimer’s and dementia
6.4.1.5 Companies are expanding operations in other cities
6.4.1.6 Advancement in technology
6.4.2 Market restraint analysis
6.4.2.1 Lower remunerations
6.4.2.2 Shortage of skilled healthcare staff
6.4.2.3 Complicated reimbursement framework and reimbursement cuts
6.5 Penetration & Growth Prospect Mapping
6.6 Business Environment Analysis tools
6.6.1 SWOT Analysis, by PEST
6.6.1.1 Political & legal
6.6.1.2 Economic
6.6.1.3 Technological & social
6.6.2 Porter’s five forces analysis
6.6.2.1 Threat of new entrants: Moderate
6.6.2.2 Bargaining power of buyers: Moderate
6.6.2.3 Competitive rivalry: High
6.6.2.4 Bargaining power of suppliers: Moderate
6.6.2.5 Threat of substitutes: Moderate
6.6.3 Industry Analysis-Ansoff Matrix
Chapter 7 Regulatory & Political Forces
7.1 North America
7.1.1 U.S.
7.1.2 Canada
7.2 Europe
7.3 Asia
Chapter 8 Reimbursement Scenario
8.1 U.S.
8.2 Canada
8.3 U.K.
8.4 Germany
8.5 France
8.6 Italy
8.7 Spain
8.8 Netherlands
8.9 Japan
8.10 Australia
8.11 Singapore
8.12 Brazil
Chapter 9 Home Healthcare Market: Component Analysis
9.1 Home Healthcare Market: Component Movement Analysis
9.2 Equipment
9.2.1 Equipment market, 2017-2030 (USD Million)
9.2.2 Therapeutic
9.2.2.1 Therapeutic market, 2017-2030 (USD Million)
9.2.2.2 Home respiratory therapy equipment
9.2.2.2.1 Home respiratory therapy equipment market, 2017-2030 (USD Million)
9.2.2.3 Insulin delivery devices
9.2.2.3.1 Insulin delivery devices market, 2017-2030 (USD Million)
9.2.2.4 Home intravenous pumps
9.2.2.4.1 Home IV pumps market, 2017-2030 (USD Million)
9.2.2.5 Home dialysis equipment
9.2.2.5.1 Home dialysis equipment market, 2017-2030 (USD Million)
9.2.2.6 Other therapeutic equipment
9.2.2.6.1 Other therapeutic equipment market, 2017-2030 (USD Million)
9.2.3 Diagnostics
9.2.3.1 Diagnostics market, 2017-2030 (USD Million)
9.2.3.2 Diabetic care unit
9.2.3.2.1 Diabetic care unit market, 2017-2030 (USD Million)
9.2.3.3 Blood pressure monitors
9.2.3.3.1 Blood pressure monitors market, 2017-2030 (USD Million)
9.2.3.4 Multi parameter diagnostic monitors
9.2.3.4.1 Multi parameter diagnostic monitors market, 2017-2030 (USD Million)
9.2.3.5 Home pregnancy and fertility kits
9.2.3.5.1 Home pregnancy and fertility kits market, 2017-2030 (USD Million)
9.2.3.6 Apnea and sleep monitors
9.2.3.6.1 Apnea and sleep monitors market, 2017-2030 (USD Million)
9.2.3.7 Holter monitors
9.2.3.7.1 Holter monitors market, 2017-2030 (USD Million)
9.2.3.8 Heart rate meters
9.2.3.8.1 Heart rate meters market, 2017-2030 (USD Million)
9.2.3.9 Others diagnostic equipment
9.2.3.9.1 Other Diagnostic Equipment market, 2017-2030 (USD Million)
9.2.4 Mobility assist equipment
9.2.4.1 Mobility assist equipment market, 2017-2030 (USD Million)
9.2.4.2 Wheelchair
9.2.4.2.1 Wheelchair market, 2017-2030 (USD Million)
9.2.4.3 Home medical furniture
9.2.4.3.1 Home medical furniture market, 2017-2030 (USD Million)
9.2.4.4 Walking assist devices
9.2.4.4.1 Walking assist devices market, 2017-2030 (USD Million)
9.3 Services
9.3.1 Services market, 2017-2030 (USD Million)
9.3.2 Skilled home healthcare
9.3.2.1 Skilled home healthcare market, 2017-2030 (USD Million)
9.3.2.2 Physician primary care
9.3.2.2.1 Physician primary care market, 2017-2030 (USD Million)
9.3.2.3 Nursing care
9.3.2.3.1 Nursing care market, 2017-2030 (USD Million)
9.3.2.4 Physical/occupational/speech therapy
9.3.2.4.1 Physical/occupational/speech therapy market, 2017-2030 (USD Million)
9.3.2.5 Nutritional support
9.3.2.5.1 Nutritional support market, 2017-2030 (USD Million)
9.3.2.6 Hospice & palliative
9.3.2.6.1 Hospice & palliative market, 2017-2030 (USD Million)
9.3.2.7 Other skilled home healthcare
9.3.2.7.1 Other skilled home healthcare market, 2017-2030 (USD Million)
9.3.3 Unskilled home healthcare
9.3.3.1 Unskilled home healthcare market, 2017-2030 (USD Million)
Chapter 10 Home Healthcare Market: Regional Outlook
10.1 Home Healthcare Market Share by Region, 2021 & 2030
10.2 Regional SWOT Analysis
10.2.1 North America
10.2.2 Europe
10.2.3 Asia Pacific
10.2.4 Latin America
10.2.5 MEA
10.3 North America
10.3.1 North America home healthcare market, 2017-2030 (USD Million)
10.3.2 U.S.
10.3.2.1 U.S. home healthcare market, 2017-2030 (USD Million)
10.3.3 Canada
10.3.3.1 Canada home healthcare market, 2017-2030 (USD Million)
10.4 Europe
10.4.1 Europe home healthcare market, 2017-2030 (USD Million)
10.4.2 U.K.
10.4.2.1 U.K. home healthcare market, 2017-2030 (USD Million)
10.4.3 Germany
10.4.3.1 Germany home healthcare market, 2017-2030 (USD Million)
10.4.4 Italy
10.4.4.1 Italy home healthcare market, 2017-2030 (USD Million)
10.4.5 Spain
10.4.5.1 Spain home healthcare market, 2017-2030 (USD Million)
10.4.6 Sweden
10.4.6.1 Sweden home healthcare market, 2017-2030 (USD Million)
10.4.7 France
10.4.7.1 France home healthcare market, 2017-2030 (USD Million)
10.4.8 Russia
10.4.8.1 Russia home healthcare market, 2017-2030 (USD Million)
10.4.9 Netherlands
10.4.9.1 Netherlands home healthcare market, 2017-2030 (USD Million)
10.5 Asia Pacific
10.5.1 Asia Pacific home healthcare market, 2017-2030 (USD Million)
10.5.2 Japan
10.5.2.1 Japan home healthcare market, 2017-2030 (USD Million)
10.5.3 China
10.5.3.1 China home healthcare market, 2017-2030 (USD Million)
10.5.4 India
10.5.4.1 India home healthcare market, 2017-2030 (USD Million)
10.5.5 Australia
10.5.5.1 Australia home healthcare market, 2017-2030 (USD Million)
10.5.6 Singapore
10.5.6.1 Singapore home healthcare market, 2017-2030 (USD Million)
10.5.7 Malaysia
10.5.7.1 Malaysia home healthcare market, 2017-2030 (USD Million)
10.5.8 Thailand
10.5.8.1 Thailand home healthcare market, 2017-2030 (USD Million)
10.5.9 Philippines
10.5.9.1 Philippines home healthcare market, 2017-2030 (USD Million)
10.5.10 South Korea
10.5.10.1 South Korea home healthcare market, 2017-2030 (USD Million)
10.6 Latin America
10.6.1 Latin America home healthcare market, 2017-2030 (USD Million)
10.6.2 Brazil
10.6.2.1 Brazil home healthcare market, 2017-2030 (USD Million)
10.6.3 Mexico
10.6.3.1 Mexico home healthcare market, 22017-2030 (USD Million)
10.6.4 Argentina
10.6.4.1 Argentina home healthcare market, 2017-2030 (USD Million)
10.7 MEA
10.7.1 MEA home healthcare market, 2017-2030 (USD Million)
10.7.2 South Africa
10.7.2.1 South Africa home healthcare market, 2017-2030 (USD Million)
10.7.3 Saudi Arabia
10.7.3.1 Saudi Arabia home healthcare market, 2017-2030 (USD Million)
10.7.4 Oman
10.7.4.1 Oman home healthcare market, 2017-2030 (USD Million)
10.7.5 UAE
10.7.5.1 UAE home healthcare market, 2017-2030 (USD Million)
10.7.6 Egypt
10.7.6.1 Egypt home healthcare market, 2017-2030 (USD Million)
Chapter 11 Competitive & Vendor Landscape
11.1 Participant Categorization
11.1.1 Innovators
11.1.1.1 Koninklijke Philips N.V.
11.1.1.2 Medtronic
11.1.1.3 Baxter
11.1.1.4 Invacare Corporation
11.1.1.5 Medline Industries Inc.
11.1.2 Market Leaders
11.1.2.1 Home healthcare equipment market
11.1.2.2 Home healthcare services market
11.1.2.2.1 List of few home healthcare service providers in the U.S.
11.1.2.2.2 List of few home healthcare service providers in Canada
11.1.2.2.3 List of few home healthcare service providers in UK
11.1.2.2.4 List of few home healthcare service providers in the Netherlands
11.1.2.2.5 List of few home healthcare service providers in Singapore
11.1.2.2.6 List of few home healthcare service providers in Australia
11.1.3 Strategy Mapping
11.1.3.1 Launch of new products
11.1.3.2 Acquisition
11.1.3.3 Expansion
11.1.3.4 Agreements, collaborations, partnerships
11.1.3.5 Others (realignment, divestment, market penetration)
11.1.3.6 Strategic initiatives
11.2 Recent Development & Impact Analysis, by Key Market Participants
Chapter 12 Company Profiles: Service Providers
12.1 KINDRED HEALTHCARE, INC.
12.1.1 Company overview
12.1.2 Financial performance
12.1.3 Service benchmarking
12.1.4 Strategic initiatives
12.2 ALMOST FAMILY, INC.
12.2.1 Company overview
12.2.2 Financial performance
12.2.3 Service benchmarking
12.2.4 Strategic initiatives
12.3 NATIONAL HEALTHCARE CORPORATION
12.3.1 Company overview
12.3.2 Financial performance
12.3.3 Service benchmarking
12.3.4 Strategic initiatives
12.4 CHUBB FIRE & SECURITY PTY LTD
12.4.1 Company overview
12.4.2 Financial performance
12.4.3 Service benchmarking
12.4.4 Strategic initiatives
12.5 GENTIVA HEALTH SERVICES, INC.
12.5.1 Company overview
12.5.2 Financial performance
12.5.3 Service benchmarking
12.5.4 Strategic initiatives
12.6 MEDCO HOME HEALTHCARE, INC.
12.6.1 Company overview
12.6.2 Service benchmarking
12.7 ADDUS HOMECARE
12.7.1 Company overview
12.7.2 Financial performance
12.7.3 Service benchmarking
12.7.4 Strategic initiatives
12.8 BROOKDALE SENIOR LIVING INC.
12.8.1 Company overview
12.8.2 Financial performance
12.8.3 Services benchmarking
12.8.4 Strategic initiatives
12.9 SUNRISE STRATFORD, LP (SUNRISE SENIOR LIVING, LLC)
12.9.1 Company overview
12.9.2 Financial performance
12.9.3 Services benchmarking
12.9.4 Strategic initiatives
12.10 GENESIS HEALTHCARE, INC.
12.10.1 Company overview
12.10.2 Financial performance
12.10.3 Service benchmarking
12.10.4 Strategic initiatives
12.11 EXTENDICARE, INC.
12.11.1 Company overview
12.11.2 Financial performance
12.11.3 Service benchmarking
12.11.4 Strategic initiatives
12.12 CAPITAL SENIOR LIVING CORPORATION
12.12.1 Company overview
12.12.2 Financial performance
12.12.3 Services benchmarking
12.12.4 Strategic initiatives
12.13 DIVERSICARE HEALTHCARE SERVICES, INC.
12.13.1 Company overview
12.13.2 Financial performance
12.13.3 Services benchmarking
12.13.4 Strategic initiatives
12.14 HOME INSTEAD, INC.
12.14.1 Company overview
12.14.2 Services benchmarking
12.14.3 Strategic initiatives
12.15 SENIOR CARE CENTERS OF AMERICA
12.15.1 Company overview
12.15.2 Services benchmarking
12.15.3 Strategic initiatives
12.16 ATRIA SENIOR LIVING, INC.
12.16.1 Company overview
12.16.2 Services benchmarking
12.16.3 Strategic initiatives
12.17 AMEDISYS, INC.
12.17.1 Company overview
12.17.2 Financial performance
12.17.3 Service benchmarking
12.17.4 Strategic initiatives
Chapter 13 Company Profiles: Suppliers
13.1 B. BRAUN MELSUNGEN AG
13.1.1 Company overview
13.1.2 Financial performance
13.1.3 Product benchmarking
13.1.4 Strategic initiatives
13.2 ABBOTT
13.2.1 Company overview
13.2.2 Financial performance
13.2.3 Product benchmarking
13.2.4 Strategic initiatives
13.3 SUNRISE MEDICAL
13.3.1 Company overview
13.3.2 Financial performance
13.3.3 Product benchmarking
13.3.4 Strategic initiatives
13.4 3M HEALTHCARE
13.4.1 Company overview
13.4.2 Financial performance
13.4.3 Product benchmarking
13.4.4 Strategic initiatives
13.5 BAXTER INTERNATIONAL INC.
13.5.1 Company overview
13.5.2 Financial performance
13.5.3 Product benchmarking
13.5.4 Strategic initiatives
13.6 MEDTRONIC PLC
13.6.1 Company overview
13.6.2 Financial performance
13.6.3 Product benchmarking
13.6.4 Strategic initiatives
13.7 CARDINAL HEALTH INC.
13.7.1 Company overview
13.7.2 Financial performance
13.7.3 Product benchmarking
13.7.4 Strategic initiatives
13.8 F. HOFFMANN-LA ROCHE AG
13.8.1 Company overview
13.8.2 Financial performance
13.8.3 Product benchmarking
13.8.4 Strategic initiatives
13.9 AIR LIQUIDE
13.9.1 Company overview
13.9.2 Financial performance
13.9.3 Product benchmarking
13.9.4 Strategic initiatives.
13.10 NXSTAGE MEDICAL, INC. (FRESENIUS MEDICAL CARE)
13.10.1 Company overview
13.10.2 Financial performance
13.10.3 Product benchmarking
13.10.4 Strategic initiatives
13.11 ARKRAY, INC.
13.11.1 Company overview
13.11.2 Product benchmarking
13.11.3 Strategic Initiatives
13.12 BECTON, DICKINSON and COMPANY
13.12.1 Company overview
13.12.2 Financial performance
13.12.3 Product benchmarking
13.12.4 Strategic initiatives
13.13 OMRON HEALTHCARE, INC.
13.13.1 Company overview
13.13.2 Financial performance
13.13.3 Product benchmarking
13.13.4 Strategic initiatives
13.14 DRIVE DEVILBISS HEALTHCARE
13.14.1 Company overview
13.14.2 Financial performance
13.14.3 Product benchmarking
13.14.4 Strategic initiatives
13.15 GE HEALTHCARE
13.15.1 Company overview
13.15.2 Financial performance
13.15.3 Product benchmarking
13.15.4 Strategic initiatives
13.16 MEDLINE INDUSTRIES, INC.
13.16.1 Company overview
13.16.2 Financial performance
13.16.3 Product benchmarking
13.16.4 Strategic initiatives
13.17 KONINKLIJKE PHILIPS N.V.
13.17.1 Company overview
13.17.2 Financial performance
13.17.3 Product benchmarking
13.17.4 Strategic initiatives
13.18 HILL-ROM, INC.
13.18.1 Company overview
13.18.2 Financial performance
13.18.3 Product benchmarking
13.18.4 Strategic initiatives
13.19 JOHNSON & JOHNSON SERVICES, INC.
13.19.1 Company overview
13.19.2 Financial performance
13.19.3 Product benchmarking
13.19.4 Strategic initiatives
13.20 LINDE HEALTHCARE
13.20.1 Company overview
13.20.2 Financial performance
13.20.3 Product benchmarking
13.20.4 Strategic initiatives
13.21 ACELITY
13.21.1 Company overview
13.21.2 Product benchmarking
13.21.3 Strategic initiatives
13.22 VYGON
13.22.1 Company overview
13.22.2 Financial performance
13.22.3 Product benchmarking
13.23 TELEFLEX, INC.
13.23.1 Company overview
13.23.2 Financial performance
13.23.3 Product benchmarking
13.24 MOOG INC.
13.24.1 Company overview
13.24.2 Financial performance
13.24.3 Product benchmarking
13.25 INTERSURGICAL LTD.
13.25.1 Company overview
13.25.2 Product benchmarking
13.26 FRESENIUS KABI AG.
13.26.1 Company overview
13.26.2 Financial performance
13.26.3 Product benchmarking
13.26.4 Strategic initiatives
13.27 BAYER HEALTHCARE
13.27.1 Company overview
13.27.2 Financial performance
13.27.3 Product benchmarking
13.27.4 Strategic initiatives
13.28 GF HEALTH PRODUCTS, INC.
13.28.1 Company overview
13.28.2 Financial performance
13.28.3 Product benchmarking
13.28.4 Strategic initiatives
Chapter 14 Recommendations

Companies Mentioned

  • B. Braun Melsungen AG
  • Abbott
  • Sunrise Medical
  • 3M Healthcare
  • Baxter International Inc.
  • Medtronic plc
  • Cardinal Health Inc.
  • F. Hoffmann-La Roche AG
  • Air Liquide
  • Nxstage Medical, Inc. (Fresenius Medical Care)
  • Arkray, Inc.
  • Becton, Dickinson and Company
  • Omron Healthcare, Inc.
  • Drive Devilbiss Healthcare
  • GE Healthcare
  • Medline Industries, Inc.
  • Koninklijke Philips N.V.
  • Hill-Rom, Inc.
  • Johnson & Johnson Services, Inc.
  • Linde Healthcare
  • Acelity
  • Vygon
  • Teleflex, Inc.
  • Moog Inc.
  • Intersurgical Ltd.
  • Fresenius Kabi Ag.
  • Bayer Healthcare
  • Gf Health Products, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages252
PublishedApril 2022
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 345.6 Billion
Forecasted Market Value ( USD ) by 2030 $ 634.9 Billion
Compound Annual Growth Rate7.9%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Smart Home Healthcare Market by Products, Technology, Service, Application - Global Forecast 2025-2030 - Product Image

Smart Home Healthcare Market by Products, Technology, Service, Application - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Home Healthcare Services Market Outlook, 2028 - Product Image

Home Healthcare Services Market Outlook, 2028

  • Report
  • 165 Pages
  • Global
From
Home Healthcare Market by Product (Dialysis Equipment, Ventilators, HIV Test Kits, Hearing Aids, Activity Monitors), Service (Skilled Nursing, Infusion Therapy, Palliative Care), Indication (Cancer, Wound Care, Diabetes), & Region - Forecast to 2028 - Product Image

Home Healthcare Market by Product (Dialysis Equipment, Ventilators, HIV Test Kits, Hearing Aids, Activity Monitors), Service (Skilled Nursing, Infusion Therapy, Palliative Care), Indication (Cancer, Wound Care, Diabetes), & Region - Forecast to 2028

  • Report
  • 342 Pages
  • Global
From
Home Healthcare Services Market Overview, 2023-2028 - Product Image

Home Healthcare Services Market Overview, 2023-2028

  • Report
  • 85 Pages
  • Global
From
Home Testing & Home Healthcare Market by Product, Component, Services Type, Application - Global Forecast 2025-2030 - Product Image

Home Testing & Home Healthcare Market by Product, Component, Services Type, Application - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.